{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:47:22Z","timestamp":1787755642478,"version":"build-2784847793"},"reference-count":61,"publisher":"Georg Thieme Verlag KG","issue":"04","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol Surg Rep"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Objective\u2003Plasmablastic lymphoma (PBL) is a type of non-Hodgkin's B-cell lymphoma associated with human immunodeficiency virus and Epstein\u2013Barr virus, commonly located in the oral cavity or gastrointestinal tract. Sinonasal involvement is rare, and there is no consensus on treatment.<\/jats:p><jats:p>\n          Data Sources\u2003Peer-reviewed published articles served as data sources.<\/jats:p><jats:p>\n          Review Methods\u2003A systematic review was conducted of the PubMed database for all cases of sinonasal PBL between 1978 and 2023 with the phrase \u201cplasmablastic lymphoma.\u201d Studies not written in English and that did not separate individual cases of sinonasal PBL from aggregated data were excluded. Age, sex, immune status, treatment, and outcomes were collected.<\/jats:p><jats:p>\n          Conclusion\u2003PBL is a rare malignancy in the sinonasal region usually treated with chemotherapy. It most commonly occurs in immunocompromised adults but has also been diagnosed in immunocompromised children and in immunocompetent adults. It is aggressive and has a poor prognosis.<\/jats:p><jats:p>\n          Implications for Practice\u2003PBL is a recently described entity with few cases of the sinonasal anatomic variant in the literature. Sinonasal PBL was most frequently treated with chemotherapy alone, closely followed by chemoradiation. The most common chemotherapy regimen utilized in the literature is cyclophosphamide, doxorubicin, oncovin\/vincristine, and prednisone, which is also the most common chemotherapy regimen in nonsinonasal PBL. A second commonly used regimen is cyclophosphamide, vincristine\/oncovin, doxorubicin\/adriamycin, and dexamethasone. However, no treatment has emerged as superior to others with regard to survival. Further data are needed to better understand this rare disease.<\/jats:p>","DOI":"10.1055\/a-2444-3438","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T01:23:04Z","timestamp":1731547384000},"page":"e167-e177","source":"Crossref","is-referenced-by-count":2,"title":["Sinonasal Plasmablastic Lymphoma: A Systematic Review"],"prefix":"10.1055","volume":"85","author":[{"given":"Sophia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, UCLA Health, Los Angeles, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidee","family":"Chen","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA, Los Angeles, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Song","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA, Los Angeles, California, United States"},{"name":"Department of Pathology and Laboratory Medicine, UCLA Health, Los Angeles, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilene B.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, UCLA Health, Los Angeles, California, United States"},{"name":"David Geffen School of Medicine at UCLA, Los Angeles, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"H J Delecluse","year":"1997","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/ijlh.13863","article-title":"Plasmablastic lymphoma: An update","volume":"44","author":"J Bailly","year":"2022","journal-title":"Int J Lab Hematol"},{"issue":"06","key":"ref3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","article-title":"Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities","volume":"28","author":"L Colomo","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"15","key":"ref4","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"J J Castillo","year":"2015","journal-title":"Blood"},{"key":"ref5","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"S H Swerdlow","year":"2008"},{"issue":"03","key":"ref6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/hiv.12965","article-title":"Plasmablastic lymphoma in Johannesburg, South Africa, in the era of widescale antiretroviral therapy use","volume":"22","author":"J Vaughan","year":"2021","journal-title":"HIV Med"},{"issue":"07","key":"ref7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"J Morscio","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.anndiagpath.2012.08.005","article-title":"Plasmablastic lymphoma in pediatric patients: clinicopathologic study of three cases","volume":"17","author":"S Pather","year":"2013","journal-title":"Ann Diagn Pathol"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7196\/sajch.613","article-title":"Plasmablastic lymphoma in childhood: a report of two cases","volume":"8","author":"J Goedhals","year":"2014","journal-title":"SAJCH"},{"issue":"21","key":"ref10","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1002\/cncr.27551","article-title":"Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy","volume":"118","author":"J J Castillo","year":"2012","journal-title":"Cancer"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3109\/10428194.2010.516040","article-title":"Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma","volume":"51","author":"J J Castillo","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.bbmt.2014.06.009","article-title":"Hematopoietic cell transplantation for plasmablastic lymphoma: a review","volume":"20","author":"M M Al-Malki","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"03","key":"ref14","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1016\/j.clml.2020.11.025","article-title":"The emerging treatment options of plasmablastic lymphoma: analysis of 173 individual patient outcomes","volume":"21","author":"N F Makady","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"NP251","DOI":"10.1177\/0145561320963715","article-title":"Unilateral maxillary sinus plasmablastic lymphoma in an immunocompetent patient. An unusual occurrence report and literature review","volume":"101","author":"N R Chicuellar","year":"2022","journal-title":"Ear Nose Throat J"},{"issue":"09","key":"ref16","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/01455613211070897","article-title":"Sinonasal plasmablastic lymphoma arising in the setting of recurrent nasal polyposis in an immunocompetent individual","volume":"103","author":"M DiBlasi","year":"2024","journal-title":"Ear Nose Throat J"},{"key":"ref17","first-page":"1142049","article-title":"Spontaneous regression of plasmablastic lymphoma in an immunocompetent patient: case report and review of the literature","volume":"2022","author":"K T Lee","year":"2022","journal-title":"Case Rep Hematol"},{"issue":"08","key":"ref18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/hiv.13266","article-title":"HIV-associated plasmablastic lymphoma: a single-centre 12-year experience in Kwa-Zulu Natal, South Africa","volume":"23","author":"N Rapiti","year":"2022","journal-title":"HIV Med"},{"issue":"07","key":"ref19","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.3390\/curroncol29070399","article-title":"Bortezomib, lenalidomide and dexamethasone combination induced complete remission in relapsed\/refractory plasmablastic lymphoma: case report of a potential novel treatment approach","volume":"29","author":"W Sabry","year":"2022","journal-title":"Curr Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"749863","DOI":"10.3389\/fmed.2021.749863","article-title":"Case report: bortezomib plus CDOP followed by sequential autologous hematopoietic stem cell transplantation and lenalidomide-based maintenance therapy in plasmablastic lymphoma","volume":"8","author":"J Cai","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"E390","DOI":"10.1002\/ajh.26291","article-title":"Complete response to pembrolizumab and radiation in a patient with HIV-negative, EBV-positive plasmablastic lymphoma","volume":"96","author":"J J Castillo","year":"2021","journal-title":"Am J Hematol"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12070-020-02266-1","article-title":"Analysis of disease patterns in patients with unilateral sinonasal diseases: a tertiary care hospital experience","volume":"74","author":"S Lasrado","year":"2022","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/1093526621999022","article-title":"EBV-positive plasmacytomas involving a nasopharyngeal angiofibroma in an adolescent","volume":"24","author":"R Mariani","year":"2021","journal-title":"Pediatr Dev Pathol"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"E389","DOI":"10.1002\/dc.24829","article-title":"An unusual case of paediatric plasmablastic lymphoma presenting with malignant effusion and the challenges in its diagnosis","volume":"49","author":"N Modi","year":"2021","journal-title":"Diagn Cytopathol"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000504608","article-title":"Bortezomib- and lenalidomide-based treatment of refractory plasmablastic lymphoma","volume":"43","author":"K Ando","year":"2020","journal-title":"Oncol Res Treat"},{"key":"ref26","first-page":"8875547","article-title":"Plasmablastic lymphoma associated with adjacent mature plasma cell population exhibiting opposite light chain restriction","volume":"2020","author":"K Furlan","year":"2020","journal-title":"Case Rep Pathol"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5045\/br.2020.55.1.49","article-title":"HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases","volume":"55","author":"Y J Li","year":"2020","journal-title":"Blood Res"},{"issue":"03","key":"ref28","first-page":"582","article-title":"Epstein-Barr virus-positive plasmacytoma in immunocompetent patients: a diagnostic dilemma","volume":"13","author":"L He","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/QAD.0000000000002590","article-title":"HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients","volume":"34","author":"B Mai","year":"2020","journal-title":"AIDS"},{"issue":"02","key":"ref30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/his.13959","article-title":"High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma","volume":"76","author":"L Miao","year":"2020","journal-title":"Histopathology"},{"issue":"01","key":"ref31","first-page":"71","article-title":"Nasal plasmablastic lymphoma in an HIV-negative immunocompetent patient","volume":"35","author":"N M Shakri","year":"2020","journal-title":"Medeniyet Med J"},{"issue":"05","key":"ref32","doi-asserted-by":"crossref","first-page":"NP222","DOI":"10.1177\/0145561320952190","article-title":"Relapse of plasmablastic lymphoma with cutaneous involvement in an immunocompetent male","volume":"101","author":"S Shwe","year":"2022","journal-title":"Ear Nose Throat J"},{"issue":"03","key":"ref33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.14740\/jh672","article-title":"Clinical features of plasmablastic lymphoma: case series from an Asian tertiary cancer center and literature review","volume":"9","author":"D RY Yap","year":"2020","journal-title":"J Hematol (Brossard)"},{"issue":"09","key":"ref34","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/jamaoto.2019.1719","article-title":"Plasmablastic lymphoma of the nasal septum","volume":"145","author":"J N Perkins","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"08","key":"ref35","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s11739-019-02192-3","article-title":"Plasmablastic lymphoma of the maxillary sinus","volume":"14","author":"A I Rodrigues","year":"2019","journal-title":"Intern Emerg Med"},{"issue":"09","key":"ref36","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/ccr3.959","article-title":"A rare case of Epstein-Barr virus-related plasmacytoma involving maxillary sinus mucosa","volume":"5","author":"J D Gibbs","year":"2017","journal-title":"Clin Case Rep"},{"key":"ref37","first-page":"9561013","article-title":"Plasmablastic lymphoma: case report of prolonged survival of an advanced human immunodeficiency patient and literature review","volume":"2017","author":"H Rafei","year":"2017","journal-title":"Case Rep Hematol"},{"issue":"04","key":"ref38","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/0956462416650124","article-title":"Clinicopathologic characteristics of HIV\/AIDS-related plasmablastic lymphoma","volume":"28","author":"D Wang","year":"2017","journal-title":"Int J STD AIDS"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anndiagpath.2016.09.002","article-title":"Solitary plasmacytoma associated with Epstein-Barr virus: a clinicopathologic, cytogenetic study and literature review","volume":"27","author":"J Yan","year":"2017","journal-title":"Ann Diagn Pathol"},{"issue":"06","key":"ref40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12185-016-2082-3","article-title":"Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases","volume":"104","author":"Y Koizumi","year":"2016","journal-title":"Int J Hematol"},{"issue":"03","key":"ref41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clml.2015.12.008","article-title":"Doxorubicin-based chemotherapy and radiation therapy produces favorable outcomes in limited-stage plasmablastic lymphoma: a single-institution review","volume":"16","author":"C C Pinnix","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"01","key":"ref42","first-page":"67","article-title":"Case report: lymphoma in a nasopharyngeal branchial cleft cyst","volume":"12","author":"N Segal","year":"2016","journal-title":"B-ENT"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13000-015-0315-z","article-title":"Clinicopathologic features of plasmablastic lymphoma: single-center series of 8 cases from Saudi Arabia","volume":"10","author":"G Elyamany","year":"2015","journal-title":"Diagn Pathol"},{"issue":"02","key":"ref44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/his.12640","article-title":"Epstein-Barr virus-positive plasmacytoma in immunocompetent patients","volume":"67","author":"S Loghavi","year":"2015","journal-title":"Histopathology"},{"issue":"09","key":"ref45","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.3109\/10428194.2015.1014364","article-title":"Proton therapy in the management of non-Hodgkin lymphoma","volume":"56","author":"S Sachsman","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"ref46","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.3324\/haematol.2014.111872","article-title":"Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection","volume":"99","author":"M R Ambrosio","year":"2014","journal-title":"Haematologica"},{"issue":"11","key":"ref47","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/pin.12212","article-title":"Plasmablastic lymphoma of the maxillary sinus with intraoral manifestation caused by direct alveolar bone infiltration in an HIV-negative patient","volume":"64","author":"R Yasuhara","year":"2014","journal-title":"Pathol Int"},{"issue":"01","key":"ref48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/2193-1801-2-142","article-title":"Plasmablastic lymphoma of the maxillary sinus in an HIV-negative patient: a case report and literature review","volume":"2","author":"C Saraceni","year":"2013","journal-title":"Springerplus"},{"issue":"06","key":"ref49","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2559.2012.04339.x","article-title":"Plasmablastic lymphoma of the elderly: a clinicopathological comparison with age-related Epstein-Barr virus-associated B cell lymphoproliferative disorder","volume":"61","author":"F Liu","year":"2012","journal-title":"Histopathology"},{"issue":"12","key":"ref50","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.leukres.2011.06.023","article-title":"Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review","volume":"35","author":"J J Liu","year":"2011","journal-title":"Leuk Res"},{"issue":"16","key":"ref51","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2169\/internalmedicine.49.3164","article-title":"CD3- and CD4-positive plasmablastic lymphoma: a literature review of Japanese plasmablastic lymphoma cases","volume":"49","author":"Y Suzuki","year":"2010","journal-title":"Intern Med"},{"issue":"04","key":"ref52","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/10428190902789173","article-title":"Human immunodeficiency virus-negative plasmablastic lymphoma in Korea","volume":"50","author":"J E Kim","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"06","key":"ref53","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/01676830903177427","article-title":"Orbital plasmablastic lymphoma\u2013comparison of a newly reported entity with diffuse large B-cell lymphoma of the orbit","volume":"28","author":"A MS Morley","year":"2009","journal-title":"Orbit"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00277-008-0601-x","article-title":"Plasmablastic lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome","volume":"88","author":"C Ustun","year":"2009","journal-title":"Ann Hematol"},{"issue":"06","key":"ref55","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2559.2003.01636.x","article-title":"Plasmablastic lymphoma in HIV+ patients: an expanding spectrum","volume":"42","author":"R Chetty","year":"2003","journal-title":"Histopathology"},{"issue":"05","key":"ref56","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/cncr.23794","article-title":"Plasmablastic lymphoma: cytologic findings in 5 cases with unusual presentation","volume":"114","author":"M Reid-Nicholson","year":"2008","journal-title":"Cancer"},{"issue":"12","key":"ref57","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/01.pas.0000173023.02724.1f","article-title":"Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm","volume":"29","author":"H Y Dong","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"03","key":"ref58","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ajh.20190","article-title":"HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum","volume":"77","author":"S A Schichman","year":"2004","journal-title":"Am J Hematol"},{"issue":"08","key":"ref59","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00277-003-0684-3","article-title":"Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report","volume":"82","author":"D D Nguyen","year":"2003","journal-title":"Ann Hematol"},{"issue":"03","key":"ref60","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1634\/theoncologist.2009-0304","article-title":"Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma","volume":"15","author":"J J Castillo","year":"2010","journal-title":"Oncologist"},{"issue":"04","key":"ref61","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41375-018-0320-9","article-title":"Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma","volume":"33","author":"A Dodero","year":"2019","journal-title":"Leukemia"},{"issue":"11","key":"ref62","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/ajh.25955","article-title":"Survival analysis in treated plasmablastic lymphoma patients: a population-based study","volume":"95","author":"J A Florindez","year":"2020","journal-title":"Am J Hematol"}],"container-title":["Journal of Neurological Surgery Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2444-3438.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T01:23:22Z","timestamp":1731547402000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2444-3438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":61,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2024,10,5]]},"published-print":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2444-3438","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2193-6358","2193-6366"],"issn-type":[{"value":"2193-6358","type":"print"},{"value":"2193-6366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}